# A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in China

> clinical trial · VERIFIED · 2026-08-03

Status: RECRUITING · Sponsor: Ipsen · Condition: Progressive Familial Intrahepatic Cholestasis

- Company: Ipsen
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT07588880

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.